Myeloma-associated Amyloidosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-07-10
Clinical Trial Update: Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant [Phase 2]
This update reports the withdrawal of a Phase 2 trial evaluating selinexor plus lenalidomide as consolidation and maintenance after stem cel…